Powered by

NuVasive returns to M&A game with Ellipse buy

Jan 06, 2016 - The Deal Pipeline
Board and Executive Moves-Mergers and Acquisitions

Fortifying its efforts to bolster its spine deformity capabilities and kicking off an expected uptick in M&A, medical technology company NuVasive Inc. (NUVA) has revealed plans to buy Ellipse Technologies Inc. for up to $410 million. According to a Tuesday, Jan.

5, statement released after the close of regular trading, NuVasive will pay $380 million in cash up front, plus an earnout of up to $30 million in 2017, contingent on Ellipse reaching specific revenue targets. The San ...